Multidrug-Resistant Tuberculosis is a significant and complex public health problem in a number of countries and an obstacle to effective Tuberculosis control, given the long duration of treatment, adverse events and…
Read more »
In 2013, the World Health Organization (WHO) estimated that less than half of all drug-resistant tuberculosis (DR-TB) cases were detected globally. Undetected resistance results in treatment failure and increases the risk of TB transmission and…
Read more »Tuberculosis (TB) remains a major cause of death and disease in low and middle-income countries (LMIC). The World Health Organization (WHO) attributed 1.3 million deaths and…
Read more »
India has more tuberculosis (TB) cases annually than any other country globally, with an estimated disease prevalence of 256/100,000 population, incidence of 185/100,000 and deaths of 26/100,000. Nationwide annual risk of TB infection (ARTI) surveys had estimated an…
Read more »Tuberculosis (TB) remains a major global public health problem even today. Despite longstanding availability of treatment, an estimated 8.6 million TB cases and 1.3 million TB deaths were reported in 2012. Early and improved case detection of TB including…
Read more »
Treatment outcomes of previously-treated smear-positive pulmonary tuberculosis (PT) patients have remained poor globally and in India. Among PT patients registered in the year 2011 in India, 71% were treated successfully as compared to…
Read more »
indicates a Peer-Reviewed Article
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
The prevalence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB is high and converge with the pandemics of HIV and diabetes, which generates…
Read more »